TXA: Difference between revisions

From Protocopedia
Jump to navigation Jump to search
No edit summary
No edit summary
 
Line 14: Line 14:
* Safe in breastfeeding
* Safe in breastfeeding


'''CONTRAINDICATIONS'''
'''CONTRAINDICATION'''
* Hypersensitivity to TXA  
* Hypersensitivity to TXA  


'''RELATIVE CONTRAINDICATION'''
'''RELATIVE CONTRAINDICATIONS'''
* Colorblindness  
* Colorblindness  
* History of Seizures  
* History of Seizures  

Latest revision as of 15:10, 8 February 2021

Section 8 - MEDICATION GUIDELINES

ANTI-FIBRINOLYTICS

Tranexamic Acid (TXA)

DESCRIPTION

  • Inhibits both plasminogen activation and plasmin activity, thus preventing clot break-down rather than promoting new clot formation. With massive bleeding this may help stabilize clot formation and decrease extravascular bleeding.

INDICATIONS

  • Severe Hemorrhagic Shock or imminent shock.
  • Strongly consider in non-traumatic major bleeding (post-partum, gastrointestinal, postoperative, nasal) with signs of shock or imminent shock.

PREGNANCY CATEGORY

  • B - Safe in Pregnancy
  • Safe in breastfeeding

CONTRAINDICATION

  • Hypersensitivity to TXA

RELATIVE CONTRAINDICATIONS

  • Colorblindness
  • History of Seizures
  • Ischemic event: Myocardial Infarction, stroke, pulmonary embolism (PE), deep venous thrombosis (DVT)
  • Isolated head injury / subarachnoid hemorrhage

PRECAUTIONS

  • Rapid injection can cause hypotension

DOSAGE

  • 1000 mg of TXA mixed in 100 ml or 250 ml of normal saline infused via IO or IV over 10 minutes.
  • 20mg/kg (1000mg maximum) TXA mixed in 100 ml of Normal Saline infused via IO or IV over 10 minutes.